Anti Angiogenesis Strategies in Cancer Therapies

Produk Detail:
  • Author : Shaker Mousa
  • Publisher : Academic Press
  • Pages : 210 pages
  • ISBN : 0128026731
  • Rating : /5 from reviews
CLICK HERE TO GET THIS BOOK >>>Anti Angiogenesis Strategies in Cancer Therapies

Download or Read online Anti Angiogenesis Strategies in Cancer Therapies full in PDF, ePub and kindle. this book written by Shaker Mousa and published by Academic Press which was released on 28 November 2016 with total page 210 pages. We cannot guarantee that Anti Angiogenesis Strategies in Cancer Therapies book is available in the library, click Get Book button and read full online book in your kindle, tablet, IPAD, PC or mobile whenever and wherever You Like. Anti-angiogenesis Strategies in Cancer Therapeutics provides a detailed look at the current status and future directions in the discovery and development of novel anti-angiogenesis strategies in oncology. This book highlights the different mechanisms involved in the modulation of angiogenesis, including inflammation, thrombosis, and microRNA, and shows how nanotechnology can further enhance the potential of existing and new anti-angiogenesis approaches. Written for industry scientists, researchers, oncologists, hematologists, and professors and students in the field, this comprehensive book covers all aspects of anti-angiogenesis strategies and their differences. Covers important preclinical models and clinical trials in the discovery and development of novel anti-angiogenesis agents Reviews FDA-approved anti-angiogenesis agents Illustrates the value of nanotechnology in improving the utility of anti-angiogenesis agents Offers insight into the development of novel anti-angiogenesis agents and future direction in this area

Anti Angiogenesis Strategies in Cancer Therapies

Anti Angiogenesis Strategies in Cancer Therapies
  • Author : Shaker Mousa,Paul Davis
  • Publisher : Academic Press
  • Release : 28 November 2016
GET THIS BOOK Anti Angiogenesis Strategies in Cancer Therapies

Anti-angiogenesis Strategies in Cancer Therapeutics provides a detailed look at the current status and future directions in the discovery and development of novel anti-angiogenesis strategies in oncology. This book highlights the different mechanisms involved in the modulation of angiogenesis, including inflammation, thrombosis, and microRNA, and shows how nanotechnology can further enhance the potential of existing and new anti-angiogenesis approaches. Written for industry scientists, researchers, oncologists, hematologists, and professors and students in the field, this comprehensive book covers all aspects of

Antiangiogenic Cancer Therapy

Antiangiogenic Cancer Therapy
  • Author : Darren W. Davis,Roy S. Herbst,James L. Abbruzzese
  • Publisher : CRC Press
  • Release : 25 July 2007
GET THIS BOOK Antiangiogenic Cancer Therapy

Top Investigators Explore the Complexities of Angiogenesis Cancer Research The targeting of tumor angiogenesis has evolved into one of the most widely pursued therapeutic strategies. However, as of yet, no antiangiogenic agent used as a monotherapy has demonstrated a survival benefit in a randomized Phase III trial. The combination of bevacizumab, the first FDA approved angiogenesis inhibitor, with cytotoxic regimens has led to survival benefits in cancer patients. This has raised important questions about the complexities inherent in the clinical

Anti Angiogenesis by a Novel VEGF Intrakine Strategy for Breast Cancer Therapy

Anti Angiogenesis by a Novel VEGF Intrakine Strategy for Breast Cancer Therapy
  • Author : Anonim
  • Publisher : Unknown
  • Release : 17 September 2021
GET THIS BOOK Anti Angiogenesis by a Novel VEGF Intrakine Strategy for Breast Cancer Therapy

Angiogenesis plays a pivotal role in tumor growth and metastasis. VEGF, an endothelial specific mitogen and an angiogenesis inducer in vivo, is one of the most important tumor angiogenesis growth factor. KDR, a VEGF receptor, appears to be the major transducer of VEGF signals in endothelial cells. A tethered intracellular antibody ("intrabody") strategy has been used successfully for both phenotypic and functional knockouts of target molecules. In this study, we have targeted a KDR single chain antibody (scFv) p3S5

Angiogenesis Modulations in Health and Disease

Angiogenesis Modulations in Health and Disease
  • Author : Shaker A. Mousa,Paul J. Davis
  • Publisher : Springer Science & Business Media
  • Release : 08 July 2014
GET THIS BOOK Angiogenesis Modulations in Health and Disease

This book is a major update of novel targets in angiogenesis modulation, including pro- and anti-angiogenesis. There is in-depth coverage of preclinical and clinical methods and models, investigational status, and clinical applications. The impact of nanotechnology in advancing the applications of pro-and anti-angiogenesis strategies is also highlighted, along with stem cell and biotechnologies in research and development of angiogenesis modulating targets.

The Effect of ZnMoS4 on Tumor Angiogenesis

The Effect of ZnMoS4 on Tumor Angiogenesis
  • Author : Haiwa Wu,Kent State University. Department of Biological Sciences,OhioLINK Electronic Theses and Dissertations Center
  • Publisher : Unknown
  • Release : 17 September 2021
GET THIS BOOK The Effect of ZnMoS4 on Tumor Angiogenesis

Angiogenesis, new blood vessel formation from preexisting ones, provides oxygen and nutrients for cells and removes waste products, therefore, it is a key step in many physical and pathological conditions. Angiogenesis is a complex and multi-step process and the molecular mechanisms that promote its progress are still not fully understood. However, abnormal angiogenesis causes many diseases, such as tumor growth and inflammatory diseases. It has been demonstrated that angiogenesis induced by tumor cells plays a pivotal role in tumor growth

Anti Angiogenesis Drug Discovery and Development

Anti Angiogenesis Drug Discovery and Development
  • Author : Atta-Ur-Rahman,Muhammad Iqbal Choudhary
  • Publisher : Elsevier Science
  • Release : 02 June 2015
GET THIS BOOK Anti Angiogenesis Drug Discovery and Development

The inhibition of angiogenesis is an effective mechanism of slowing down tumor growth and malignancies. The process of induction or pro-angiogenesis is highly desirable for the treatment of cardiovascular diseases, wound healing disorders, and more. Efforts to understand the molecular basis, both for inhibition and induction, have yielded fascinating results. Originally published by Bentham and now distributed by Elsevier, Anti-Angiogenesis Drug Discovery and Development, Volume 2 is an compilation of well-written reviews on various aspects of the anti-angiogenesis process. These reviews

Gene Therapy for Lung Cancer by Adeno Associated Virus Mediated Expression of Angiogenesis Inhibitors in Mouse Models

Gene Therapy for Lung Cancer by Adeno Associated Virus Mediated Expression of Angiogenesis Inhibitors in Mouse Models
  • Author : Kexia Cai
  • Publisher : Open Dissertation Press
  • Release : 27 January 2017
GET THIS BOOK Gene Therapy for Lung Cancer by Adeno Associated Virus Mediated Expression of Angiogenesis Inhibitors in Mouse Models

This dissertation, "Gene Therapy for Lung Cancer by Adeno-associated Virus-mediated Expression of Angiogenesis Inhibitors in Mouse Models" by Kexia, Cai, 蔡克瑕, was obtained from The University of Hong Kong (Pokfulam, Hong Kong) and is being sold pursuant to Creative Commons: Attribution 3.0 Hong Kong License. The content of this dissertation has not been altered in any way. We have altered the formatting in order to facilitate the ease of printing and reading of the dissertation. All rights not granted by the above

Advances in Targeted Cancer Therapy

Advances in Targeted Cancer Therapy
  • Author : Richard M. Schultz
  • Publisher : Springer Science & Business Media
  • Release : 24 January 2006
GET THIS BOOK Advances in Targeted Cancer Therapy

There have been tremendous advances in our understanding of molecular and tumor biology during the past few years. In the field of cancer therapeutics, it is expected that cytotoxic drug approaches will be gradually replaced with treatments based on biological targeted approaches. Hopefully these new targeted therapies will significantly increase efficacy and lack the devastating and troublesome side effects elicited by cytotoxic chemotherapy. This volume is the first book to cover the general topic of targeted cancer therapy. It presents

Principles of Cancer Biotherapy

Principles of Cancer Biotherapy
  • Author : Robert K. Oldham,Robert O. Dillman
  • Publisher : Springer Science & Business Media
  • Release : 29 August 2009
GET THIS BOOK Principles of Cancer Biotherapy

At the time of the first edition of Principles of Cancer Biotherapy in 1987, this book represented the first comprehensive textbook on biological therapy. In 1991, when the second edition was published, there was still some doubt on the part of many oncologists and cancer researchers as to the therapeutic value of these new approaches. By 2003 and the fourth edition, it was generally agreed that biopharmaceuticals were producing major opportunities for new cancer therapies. Cancer biotherapy has now truly matured into the

Anti Angiogenesis Drug Discovery and Development

Anti Angiogenesis Drug Discovery and Development
  • Author : Atta-ur-Rahman,Muhammad Iqbal Choudhary
  • Publisher : Elsevier
  • Release : 16 June 2015
GET THIS BOOK Anti Angiogenesis Drug Discovery and Development

The inhibition of angiogenesis is an effective mechanism of slowing down tumor growth and malignancies. The process of induction or pro-angiogenesis is highly desirable for the treatment of cardiovascular diseases, wound healing disorders, and more. Efforts to understand the molecular basis, both for inhibition and induction, have yielded fascinating results. Originally published by Bentham and now distributed by Elsevier, Anti-Angiogenesis Drug Discovery and Development, Volume 2 is an compilation of well-written reviews on various aspects of the anti-angiogenesis process. These reviews

Mechanisms of Drug Resistance in Cancer Therapy

Mechanisms of Drug Resistance in Cancer Therapy
  • Author : Mario Mandalà,Emanuela Romano
  • Publisher : Springer
  • Release : 10 January 2019
GET THIS BOOK Mechanisms of Drug Resistance in Cancer Therapy

A major objective of this book is to reveal unprecedented opportunities to understand and overcome drug resistance through the clinical assessment of rational therapeutic drug combinations and the use of predictive and prognostic biomarkers to enable patient stratification and tailor treatments. It offers to the readers an updated overview on the possible reasons of failure of new and promising therapeutic opportunities.

Therapy for Ocular Angiogenesis

Therapy for Ocular Angiogenesis
  • Author : Arup Das,Thomas Friberg
  • Publisher : Lippincott Williams & Wilkins
  • Release : 28 March 2012
GET THIS BOOK Therapy for Ocular Angiogenesis

Ocular angiogenesis, or the abnormal growth of blood vessels in the eye, is the cause of major neovascular eye diseases. With the new era of anti-angiogenic therapies, ophthalmologists have started treating many ocular diseases including macular degeneration, diabetic retinopathy, and retinal vascular occlusion using anti-angiogenic drugs. This book covers the basic pathophysiology of ocular angiogenesis and strategies for inhibition. The authors discuss the "Principles" of anti-angiogenic therapy, pre-clinical studies, future drugs on the horizon, drug delivery, and the "Practice" of

Introduction to Cancer Biology

Introduction to Cancer Biology
  • Author : Robin Hesketh
  • Publisher : Cambridge University Press
  • Release : 17 September 2021
GET THIS BOOK Introduction to Cancer Biology

A concise overview of the fundamental concepts of cancer biology, ideal for those with little or no background in the field. From cancer epidemiology and the underlying mechanisms, through to tumour detection and treatment, the comprehensive picture revealed will enable students to move into the cancer field with confidence.